Utama › Stroke Iskemia › Alabama
Kajian klinikal Stroke Iskemia di Alabama
8 kajian untuk Stroke Iskemia sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
- Mobile Infirmary Medical Center, Mobile
Mengambil pesertaFasa 3
Umur 18 hingga 79 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05611242Strategy for Improving Stroke Treatment Response
- University of Alabama Hospital, Birmingham
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05948566Continuous Dual Aspiration Technique With Zoom System for Stroke
- Huntsville Hospital, Huntsville
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07491952Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- SEC Clinical Research, Dothan
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07430956Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- Gulf Health Hospitals d/b/a Thomas Hospital, Fairhope
Mengambil pesertaFasa 2/3
Umur 18 hingga 90 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05065216Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05911568Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
- Birmingham VA Medical Center, Birmingham
- University of Alabama, Birmingham
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05338697StrokeNet Thrombectomy Endovascular Platform
- University of Alabama Hospital, Birmingham
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Dis 2025 · NCT06289985Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.